financing acquisition; D. or isomerizing actions (42, 43). Even though the active oxidoreductase theme, Cys-Xaa-Xaa-Cys, isn’t present in these domains, the multiple Cys residues within SGC 0946 UGGT1 as well
ROCK inhibitors
financing acquisition; D. or isomerizing actions (42, 43). Even though the active oxidoreductase theme, Cys-Xaa-Xaa-Cys, isn’t present in these domains, the multiple Cys residues within SGC 0946 UGGT1 as well